VEGF levels were significantly increased in lung cancer cells and NSCLC tissues with EGFR mutations (Hung et al., 2016), and the enhanced expression of VEGF is frequently related to the resistance of EGFR-TKI (Hung et al., 2016). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.